pre-miRNA Information
pre-miRNA hsa-mir-3200   
Genomic Coordinates chr22: 30731557 - 30731641
Description Homo sapiens miR-3200 stem-loop
Comment None
RNA Secondary Structure

Mature miRNA Information
Mature miRNA hsa-miR-3200-3p
Sequence 54| CACCUUGCGCUACUCAGGUCUG |75
Evidence Experimental
Experiments Illumina
SNPs in miRNA
Mutant ID Mutant Position Mutant Source
rs1354947096 9 dbSNP
Putative Targets

miRNA Expression profile
Human miRNA Tissue Atlas
miRNAs in Extracellular Vesicles
Circulating MicroRNA Expression Profiling
Gene Information
Gene Symbol RPSA   
Synonyms 37LRP, 67LR, ICAS, LAMBR, LAMR1, LBP, LBP/p40, LRP, LRP/LR, NEM/1CHD4, SA, lamR, p40
Description ribosomal protein SA
Transcript NM_002295   
Expression
Putative miRNA Targets on RPSA
3'UTR of RPSA
(miRNA target sites are highlighted)
>RPSA|NM_002295|3'UTR
   1 GCTGTTCTTGCATAGGCTCTTAAGCAGCATGGAAAAATGGTTGATGGAAAATAAACATCAGTTTCTAAAAGTTGTCTTCA
  81 TTTAGTTTGCTTTTTACTCCAGATCAGAATACCTGGGATTGCATATCAAAGCATAATAATAAATACATGTCTCGACATGA
 161 GTTGTACTTCTAAAAAAAAAAAAAAAAAA
Target sites Provided by authors   Predicted by miRanda    DRVs    SNPs    DRVs & SNPs
miRNA-target interactions
(Predicted by miRanda)
ID Duplex structure Position Score MFE
1
miRNA  3' guCUGGACUCAUCG-CGUUCCac 5'
            | :|| |  ||| ||| ||  
Target 5' agGCTCTTA--AGCAGCATGGaa 3'
14 - 34 100.00 -9.20
2
miRNA  3' gucUGGACUCAUCGCGUuccac 5'
             |||||:| | :|||     
Target 5' aatACCTGGG-ATTGCAtatca 3'
108 - 128 86.00 -11.63
3
miRNA  3' guCUGGACUCAUCGCGUuccac 5'
            ||| |||||  :|:|     
Target 5' tcGACATGAGT--TGTActtct 3'
152 - 171 72.00 -7.23
DRVs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
COSN29462101 15 COSMIC
COSN26665559 28 COSMIC
COSN31586582 28 COSMIC
COSN30152834 66 COSMIC
COSN31579926 87 COSMIC
COSN20069130 164 COSMIC
SNPs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
rs745630638 5 dbSNP
rs775402341 6 dbSNP
rs746957644 7 dbSNP
rs769811769 8 dbSNP
rs545703827 10 dbSNP
rs766485272 12 dbSNP
rs774689053 13 dbSNP
rs759970132 17 dbSNP
rs1291599698 20 dbSNP
rs767994374 22 dbSNP
rs1041347114 24 dbSNP
rs1355088146 25 dbSNP
rs887019850 28 dbSNP
rs753196270 36 dbSNP
rs1308728570 37 dbSNP
rs1465093148 38 dbSNP
rs1375536498 39 dbSNP
rs756710364 53 dbSNP
rs1328084762 58 dbSNP
rs1313373578 62 dbSNP
rs1429264471 64 dbSNP
rs1335053880 66 dbSNP
rs1175534583 78 dbSNP
rs1238424522 80 dbSNP
rs565402392 91 dbSNP
rs772441203 107 dbSNP
rs559288026 114 dbSNP
rs531161498 129 dbSNP
rs1471349635 134 dbSNP
rs577649232 148 dbSNP
rs751231360 151 dbSNP
rs74680958 154 dbSNP
rs746601718 162 dbSNP
rs1463301250 165 dbSNP
rs1210926610 169 dbSNP
rs1298706184 170 dbSNP
rs1202495503 171 dbSNP
rs1257525184 173 dbSNP
Experimental Support 1 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
     
Conditions Flp-In T-REx 293-hAGO1 cells
Location of target site CDS
Original Description (Extracted from the article) ... Validation of interactions identified by CLASH suppports their reliability. ...

- Helwak A; Kudla G; Dudnakova T; Tollervey D, 2013, Cell.

Article - Helwak A; Kudla G; Dudnakova T; Tollervey D
- Cell, 2013
MicroRNAs (miRNAs) play key roles in gene regulation, but reliable bioinformatic or experimental identification of their targets remains difficult. To provide an unbiased view of human miRNA targets, we developed a technique for ligation and sequencing of miRNA-target RNA duplexes associated with human AGO1. Here, we report data sets of more than 18,000 high-confidence miRNA-mRNA interactions. The binding of most miRNAs includes the 5' seed region, but around 60% of seed interactions are noncanonical, containing bulged or mismatched nucleotides. Moreover, seed interactions are generally accompanied by specific, nonseed base pairing. 18% of miRNA-mRNA interactions involve the miRNA 3' end, with little evidence for 5' contacts, and some of these were functionally validated. Analyses of miRNA:mRNA base pairing showed that miRNA species systematically differ in their target RNA interactions, and strongly overrepresented motifs were found in the interaction sites of several miRNAs. We speculate that these affect the response of RISC to miRNA-target binding.
LinkOut: [PMID: 23622248]
MiRNA-Target Expression Profile
Dataset Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
MiRNA-Target Expression Profile (TCGA)
Tumor Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
PCPG -0.999 0.01 -1.000 0.5 3 Click to see details
STAD -0.371 0.02 -0.307 0.05 31 Click to see details
UCEC -0.466 0.02 -0.451 0.03 19 Click to see details
LUAD -0.556 0.06 -0.400 0.14 9 Click to see details
KIRP -0.272 0.07 -0.192 0.15 32 Click to see details
LIHC 0.166 0.14 0.139 0.18 45 Click to see details
PRAD -0.167 0.14 -0.052 0.37 44 Click to see details
LUSC -0.167 0.16 -0.088 0.3 38 Click to see details
KICH -0.172 0.21 -0.100 0.32 25 Click to see details
CESC 0.789 0.21 1.000 0.5 3 Click to see details
BLCA -0.173 0.26 0.062 0.41 16 Click to see details
THCA -0.064 0.32 -0.044 0.37 59 Click to see details
CHOL -0.193 0.32 -0.048 0.46 8 Click to see details
KIRC 0.048 0.35 0.056 0.33 65 Click to see details
HNSC 0.061 0.36 0.034 0.42 38 Click to see details
BRCA 0.032 0.39 0.027 0.41 73 Click to see details
ESCA 0.046 0.46 0.071 0.44 7 Click to see details
PAAD -0.025 0.49 -0.400 0.3 4 Click to see details
PAAD -0.025 0.49 -0.400 0.3 4 Click to see details
35 hsa-miR-3200-3p Target Genes:
Functional analysis:
ID Target Description Validation methods
Strong evidence Less strong evidence
MIRT052815 CDC37 cell division cycle 37 1 1
MIRT052816 ATP6V1E2 ATPase H+ transporting V1 subunit E2 1 1
MIRT052817 MCM3AP minichromosome maintenance complex component 3 associated protein 1 1
MIRT052818 NSUN4 NOP2/Sun RNA methyltransferase family member 4 1 1
MIRT052819 EXOC4 exocyst complex component 4 1 1
MIRT052820 DDB1 damage specific DNA binding protein 1 1 1
MIRT052821 CAD carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase 1 1
MIRT052822 RPL23 ribosomal protein L23 1 1
MIRT052823 TPT1 tumor protein, translationally-controlled 1 1 1
MIRT052824 RPSA ribosomal protein SA 1 1
MIRT052825 PPIA peptidylprolyl isomerase A 1 1
MIRT052826 SSRP1 structure specific recognition protein 1 1 1
MIRT052827 STX2 syntaxin 2 1 1
MIRT095464 PURA purine rich element binding protein A 2 4
MIRT325192 PSAT1 phosphoserine aminotransferase 1 2 2
MIRT447293 ZNF562 zinc finger protein 562 2 2
MIRT450360 GRAMD3 GRAM domain containing 2B 2 2
MIRT482917 ZNF845 zinc finger protein 845 2 2
MIRT498302 DCAF8 DDB1 and CUL4 associated factor 8 2 2
MIRT500041 PABPC3 poly(A) binding protein cytoplasmic 3 2 8
MIRT541475 ARHGAP12 Rho GTPase activating protein 12 2 12
MIRT556269 MAPK6 mitogen-activated protein kinase 6 2 2
MIRT565440 SURF4 surfeit 4 2 2
MIRT573386 GPR20 G protein-coupled receptor 20 2 2
MIRT627911 OCIAD2 OCIA domain containing 2 2 2
MIRT633645 SKAP2 src kinase associated phosphoprotein 2 2 2
MIRT643472 PDK3 pyruvate dehydrogenase kinase 3 2 2
MIRT646284 GALNT2 polypeptide N-acetylgalactosaminyltransferase 2 2 2
MIRT647889 CD55 CD55 molecule (Cromer blood group) 2 2
MIRT664712 EIF4G3 eukaryotic translation initiation factor 4 gamma 3 2 2
MIRT668135 GINS2 GINS complex subunit 2 2 2
MIRT686490 TRIOBP TRIO and F-actin binding protein 2 2
MIRT709525 IGF2 insulin like growth factor 2 2 2
MIRT722252 NTMT1 N-terminal Xaa-Pro-Lys N-methyltransferase 1 2 2
MIRT755478 CAMK2A calcium/calmodulin dependent protein kinase II alpha 4 1
miRNA-Drug Resistance Associations
miRNA Drug Name CID NSC FDA Effect/Pattern Detection Method Level Phenotype Condition
hsa-mir-3200 Tamoxifen 2733525 NSC180973 approved resistant High Breast Cancer cell line (MCF-7, T47D)
hsa-mir-3200 Cisplatin 5460033 NSC119875 approved resistant High Gastric Cancer cell line (BGC823)
hsa-mir-3200 Ceritinib 57379345 NSC776422 approved sensitive High Non-Small Cell Lung Cancer cell line (H3122, H2228)
hsa-mir-3200 Tamoxifen 2733525 NSC180973 approved resistant cell line (MCF7)
hsa-mir-3200 Ceritinib 57379345 NSC776422 approved sensitive cell line (H3122)
hsa-mir-3200 Cisplatin 5460033 NSC119875 approved resistant cell line (BGC-823)
hsa-miR-3200-3p Fluorouracil 3385 NSC19893 approved resistant High Pancreatic Cancer cell line (PANC-1)
hsa-miR-3200-3p Gemcitabine 60750 NSC613327 approved resistant High Pancreatic Cancer cell line (PANC-1)
hsa-miR-3200-3p Plx-4720 24180719 NSC757438 sensitive High Thyroid Cancer cell line (8505c, BCPAP)
hsa-miR-3200-3p Ceritinib 57379345 NSC776422 approved sensitive High Non-Small Cell Lung Cancer cell line (H3122, H2228)
hsa-miR-3200-3p Vemurafenib 42611257 NSC761431 approved resistant cell line (451Lu)
hsa-miR-3200-3p Cisplatin 5460033 NSC119875 approved sensitive cell line
hsa-miR-3200-3p Gefitinib 123631 NSC715055 approved sensitive cell line (HCC827)
hsa-miR-3200-3p Paclitaxel 36314 NSC125973 approved sensitive cell line (HS578T)
hsa-miR-3200-3p Doxorubicin 31703 NSC123127 approved sensitive cell line (HS578T)
hsa-miR-3200-3p Fluorouracil 3385 NSC19893 approved sensitive cell line (HCT15)
hsa-miR-3200-3p Platinum 23939 resistant tissue (non-small cell lung cancer)
hsa-miR-3200-3p Cisplatin 5460033 NSC119875 approved sensitive cell line (A549)
hsa-miR-3200-3p Ceritinib 57379345 NSC776422 approved sensitive cell line (H3122)
hsa-miR-3200-3p Paclitaxel/Docetaxel/Vinorelbine/Doxorubicin/Etoposide sensitive cell line (Bads-200)

Error report submission